Pancreatic cancer: Local success and distant failure

Oncologist

Volumn 3, Issue 3, 1998, Pages 178-188

  Ryan, David P ^a,b   Grossbard, Michael L ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Adjuvant therapy; Clinical trials; Combined modality therapy; Pancreatic neoplasms; Pancreaticoduodenectomy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EDATREXATE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; METHOTREXATE; OCTREOTIDE; PACLITAXEL; VINCRISTINE;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; HUMAN; PANCREAS CANCER; PATIENT CARE; PRIORITY JOURNAL;

EID: 0031802244     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.3-3-178     Document Type: Article

References (12)

1. Landis S, Taylor M, Bolden S et al. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-30.
2. Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447-458.
3. Whittington R, Bryer MP, Haller DG et al. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1991;21:1137-1143.
4. Bakkevold KE, Arnesj B, Dahl O et al. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater: results of a controlled, prospective, randomised multicentre study. Eur J Cancer 1993;29:698-703a.
5. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68-73.
6. Tsao JI, Rossi RL, Lowell JA. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation (published erratum appears in Arch Surg 1994;129:1164). Arch Surg 1994;129:405-412.
7. Zerbi A, Fossati V, Parolini D et al. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 1994;73:2930-2935.
8. Yeo CJ, Cameron JL, Lillemoe KD et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:721-733.
9. Staley CA, Lee JE, Cleary KR et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996;171:118-125.
10. Crown J, Casper ES, Botet J et al. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. J Clin Oncol 1991;9:1682-1686.
11. DeCaprio JA, Mayer RJ, Gonin R et al. Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial. J Clin Oncol 1991;9:2128-2133.
12. Mallinson CN, Rake MO, Cocking JB et al. Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial. Br Med J 1980;281:1589-1591.